X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D | 2025-02-19 | SLDB | Bain Capital Life Sciences Investors, LLC | 10% | P - Purchase | $4.03 | +1,000,000 | 5,034,582 | +25% | +$4,030,000 | |||||
2025-02-19 | SLDB | Perceptive Advisors LLC | Dir, 10% | P - Purchase | $4.03 | +5,000,000 | 11,906,646 | +72% | +$20,150,000 | ||||||
2025-02-18 | SLDB | Adage Capital Management, L.P. | 10% | P - Purchase | $7.56 | +252,545 | 4,248,084 | +6% | +$1,909,240 | ||||||
D | 2025-02-14 | SLDB | Hanrahan Jessie | Chief Regulatory Officer | S - Sale+OE | $3.96 | -3,079 | 19,281 | -14% | -$12,193 | |||||
D | 2025-02-14 | SLDB | Brooks Gabriel | Chief Medical Officer | S - Sale+OE | $3.96 | -3,256 | 22,812 | -12% | -$12,894 | |||||
D | 2025-02-14 | SLDB | Tan Kevin | CFO, Treasurer | S - Sale+OE | $3.96 | -3,164 | 32,250 | -9% | -$12,529 | |||||
D | 2025-02-14 | SLDB | Howton David T | COO | S - Sale+OE | $3.96 | -5,561 | 24,789 | -18% | -$22,022 | |||||
D | 2025-02-14 | SLDB | Herzich Paul | CTO | S - Sale+OE | $3.96 | -2,688 | 18,388 | -13% | -$10,644 | |||||
D | 2025-02-14 | SLDB | Cumbo Alexander | Pres, CEO | S - Sale+OE | $3.96 | -11,365 | 60,717 | -16% | -$45,005 | |||||
D | 2025-02-14 | SLDB | Ganot Ilan | Dir | S - Sale+OE | $3.96 | -1,711 | 132,923 | -1% | -$6,776 | |||||
D | 2025-01-28 | SLDB | Ganot Ilan | Dir | S - Sale+OE | $3.11 | -144 | 129,773 | 0% | -$448 | |||||
D | 2025-01-10 | SLDB | Tan Kevin | CFO, Treasurer | S - Sale+OE | $3.89 | -4,073 | 24,789 | -14% | -$15,849 | |||||
D | 2025-01-06 | SLDB | Ganot Ilan | Dir | S - Sale+OE | $4.31 | -1,056 | 125,646 | -1% | -$4,551 | |||||
D | 2024-12-03 | SLDB | Hanrahan Jessie | Chief Regulatory Officer | S - Sale+OE | $5.60 | -4,610 | 14,235 | -24% | -$25,822 | |||||
D | 2024-12-03 | SLDB | Cumbo Alexander | Pres, CEO | S - Sale+OE | $5.60 | -11,114 | 38,484 | -22% | -$62,236 | |||||
D | 2024-12-03 | SLDB | Howton David T | COO | S - Sale+OE | $5.60 | -5,072 | 15,663 | -24% | -$28,396 | |||||
D | 2024-12-03 | SLDB | Herzich Paul | CTO | S - Sale+OE | $5.60 | -2,777 | 12,182 | -19% | -$15,551 | |||||
D | 2024-10-21 | SLDB | Brooks Gabriel | Chief Medical Officer | S - Sale+OE | $6.50 | -2,923 | 10,979 | -21% | -$19,000 | |||||
2024-06-07 | SLDB | Kahn Clare | Dir | P - Purchase | $7.67 | +1,100 | 1,100 | New | +$8,442 | ||||||
D | 2024-05-02 | SLDB | Ganot Ilan | Dir | S - Sale+OE | $10.33 | -462 | 123,708 | 0% | -$4,772 | |||||
D | 2024-01-29 | SLDB | Ganot Ilan | Dir | S - Sale+OE | $7.99 | -139 | 122,617 | 0% | -$1,111 | |||||
2024-01-11 | SLDB | Perceptive Advisors LLC | Dir, 10% | P - Purchase | $5.53 | +3,410,713 | 6,906,646 | +98% | +$18,861,243 | ||||||
2024-01-11 | SLDB | Ra Capital Management, L.P. | Dir, 10% | P - Purchase | $5.53 | +904,160 | 4,301,877 | +27% | +$5,000,005 | ||||||
D | 2024-01-09 | SLDB | Tan Kevin | CFO, Treasurer | S - Sale+OE | $8.20 | -3,935 | 9,308 | -30% | -$32,267 | |||||
D | 2024-01-03 | SLDB | Ganot Ilan | Dir | S - Sale+OE | $5.30 | -1,142 | 118,485 | -1% | -$6,052 | |||||
D | 2023-12-04 | SLDB | Cumbo Alexander | Pres, CEO | S - Sale+OE | $2.77 | -11,757 | 17,439 | -40% | -$32,516 | |||||
D | 2023-12-04 | SLDB | Howton David T | COO | S - Sale+OE | $2.78 | -5,367 | 7,684 | -41% | -$14,920 | |||||
D | 2023-12-04 | SLDB | Herzich Paul | CTO | S - Sale+OE | $2.77 | -2,968 | 4,270 | -41% | -$8,232 | |||||
D | 2023-12-04 | SLDB | Hanrahan Jessie | Chief Regulatory Officer | S - Sale+OE | $2.78 | -4,879 | 6,983 | -41% | -$13,562 | |||||
D | 2023-12-04 | SLDB | Marlowe Jennifer | CSO | S - Sale+OE | $2.77 | -4,890 | 6,998 | -41% | -$13,525 | |||||
D | 2023-05-02 | SLDB | Ganot Ilan | Dir | S - Sale+OE | $4.85 | -487 | 111,305 | 0% | -$2,364 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |